Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study
Clinical trial NCT01161394 · COMPLETED
Trial details
- NCT number
- NCT01161394
- Sponsor
- University at Buffalo
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.